Page last updated: 2024-09-05

sorafenib and Opportunistic Infections

sorafenib has been researched along with Opportunistic Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carbotti, M; Coppola, R; De Florio, L; Galati, G; Graziano, A; Panasiti, V; Rinati, MV; Zanframundo, S1

Other Studies

1 other study(ies) available for sorafenib and Opportunistic Infections

ArticleYear
Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:5

    Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Dermatomycoses; Humans; Liver Neoplasms; Male; Niacinamide; Opportunistic Infections; Phenylurea Compounds; Rhodotorula; Sorafenib

2015